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o-, m- & p-PhenylenediamineAbstract A series of nine new biologically active Schiff bases 5a–i were synthesized by a conden-
sation of 4-acyl-5-pyrazolones 3a–c with aromatic diamines 4a–d, and characterized by elemental
analysis, mass and spectroscopic data. All the compounds showed antibacterial activity against
Bacillus subtilis and Escherichia coli, good antifungal activity against Phytophthora infestanse and
Aspergillus niger, and ferric-reducing antioxidant power (FRAP).
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
5-Pyrazolone is a widely used precursor to a variety of com-
pounds, documented well for their numerous applications
such as products and intermediates in analytical, agricul-
tural, biological, and pharmaceutical chemistry (Jung et al.,
2002; Kimata et al., 2007; Varvounis et al., 2007; Bojan
et al., 2009). Some of them also serve as important pharma-
ceutical agents including. antipyrine and its congeners. With
continuous evaluation for their pharmacological properties
like analgesic (Gu¨rsoy et al., 2000), anti-inﬂammatory (Sat-
yanarayana and Rao, 1995), antiarrhythmic, antifungal
(Bekhit and Fahmy, 2003), potential antipyretic (Souzaet al., 2002), antinociceptive (Tabarelli et al., 2004; Prokopp
et al., 2006) and antioxidant activities (Godoy et al., 2004),
the pyrazolone derivatives have still attracted medicinal
chemist’s interest. Recently, acylpyrazolones have been re-
ported to have a multidrug resistance modulating activity
(Kimata et al., 2007). Benzoylpyrazolones, particularly, are
potential antiprion agents (Chiba et al., 1998). From our
laboratory, many reports exist on a ligational behaviour of
pyrazolone based Schiff compounds. But, to the best of
our knowledge, no reports exist on their biological evalua-
tion. The presence of fragment –N‚CH–R in Schiff bases
is known for its biological activity (Shemarova et al.,
2000; Rehab et al., 2010). Many reports exist on struc-
ture–activity relationship of the class of these compounds
(More et al., 2002; Bhendkar et al., 2004). Thus, it seems
worthwhile to continue to investigate in this area. In the
present work, we report synthesis, antimicrobial and antiox-
idant activities of some 5-pyrazolone based Schiff bases de-
rived from a condensation reaction of 4-acyl-5-pyrazolones
with aromatic diamines.
Synthesis, antimicrobial and antioxidant activities of some 5-pyrazolone based Schiff bases 372. Experimental section
2.1. General
All chemicals used were of laboratory reagent grade and used
without further puriﬁcation. Phenyl hydrazine was obtained
from Sd. Fine Chem. Pvt. Ltd., Mumbai, India. Ethyl acetoac-
etate and calcium hydroxide were obtained from Samir Tech
Chem. Pvt. Ltd., Vadodara, India. Diethyl ether and butyryl
chloride were used as received from Merck, Mumbai, India.
1,4-Dioxane was supplied by Sisco Chem. Pvt. Ltd., Mumbai,
India. Benzoyl chloride and Acetyl chloride were obtained
from Chemport (India) Pvt. Ltd., Mumbai, India.
2.2. Analytical methods
All melting points were taken in open capillaries and are
uncorrected. IR spectra were recorded, in KBr disc, on Perkin-
Elmer Spectrum GX FTIR spectrometer and are reported in
wavenumbers (cm1). 1H NMR and 13C NMR spectra (ppm,
d) were recorded on a Bruker Avance 400 spectrometer oper-
ating at 400 MHz for 1H NMR, and 100 MHz for 13C NMR
using CDCl3 or DMSO d6 as solvent and reference. A degree
of substitution (C, CH, CH2, and CH3) was determined by
the DEPT-135 method. Carbon, Hydrogen and Nitrogen were
estimated on a PerkinElmer 2400 Series II CHNS/O Elemental
Analyzer. ESI mass spectra were measured on Thermo TSQ
Quantum Access mass spectrometer at SICART, Vallabh Vid-
yanagar, Gujarat, India. Thin-layer chromatography (TLC, on
aluminium plates coated with silica gel 60 F254, 0.25 mm thick-
ness, Merck) was used for monitoring the progress of the reac-
tion, purity and homogeneity of the synthesized compounds.N
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2.3.1. The preparation of 4-acyl-phenyl-3-methyl-5-pyrazolones
3a–c
4-Acyl-5-pyrazolones were prepared by reported methods. A
corresponding acyl chloride (0.1 mol, 7.85 g acetyl chloride
2a, 15.20 g benzoyl chloride 2b and 10.60 g butyryl chloride
2c) was added to a well stirred, suspended with calcium
hydroxide (12 g), solution of 5-pyrazolone 1 (0.1 mol, 17.4 g)
in 1,4-dioxane (70–80 mL) at room temperature. Temperature
increased for the ﬁrst 5 min due to the exothermic nature of the
reaction. After the complete addition, the resulted mass was
treated according to the type of acylchloride taken. When bu-
tyryl chloride used, it was just stirred at room temperature for
45 min (Okafor et al., 1993). In all other cases, the mass was
reﬂuxed for 30 min (Jenson, 1956). Resulted mass obtained
either in any ways, was then acidiﬁed by ice cold diluted hydro-
chloric acid (2 N, 200 mL), followed by a continuous stirring
to cream colour crystals.
2.3.2. The synthesis of Schiff bases 5a–i
A mixture of an equimolar ethanolic hot solution (50 mL) of
respective diamines 4a–d (1.08 g of 4a or 4b or 4d and 1.22 g
of 4c) with corresponding acylpyrazolones 3a–c (0.01 mol,
2.16 g of 3a, 2.78 g of 3b or 2.44 g of 3c), in the presence of
a few drops of acetic acid, was reﬂuxed for 3 h. After the com-
pletion of reaction as monitored by TLC, it was then cooledand allowed to stand overnight at room temperature. The col-
oured crystalline products 5a–i were obtained in good yield
with excellent purity. It was washed with cold ethanol followed
by drying at 60–90 C (Scheme 1, Table 1). The spectral char-
acterizations of the compounds are given below:
2.3.2.1. 4-(1-(2-Aminophenylimino)ethyl)-3-methyl-1-phenyl-
1H-pyrazol-5-ol 5a. Recrystallized from ethanol (yield 60%),
obtained as yellow crystals. mp 200–202 C. Anal. Calcd for
C18H18N4O (306.36): C, 70.57; H, 5.92; N, 18.29. Found: C,
70.68; H, 5.85; N, 18.40; 1H-NMR (CDCl3) d; 2.27 (s, 3H,
CH3), 2.42 (s, 3H, COCH3), 3.78 (s, 2H, NH2), 6.83–8.02 (m,
9H, Ar-H), 12.59 (s, 1H, OH); 13C NMR (CDCl3) d; 16.51,
17.33, 100.27, 116.70, 118.50, 118.86, 119.12, 122.21, 124.08,
127.45, 128.58, 129.13, 139.03, 142.24, 147.36, 165.64; IR mmax
cm1(KBr): 3440, 3349, 1620, 1393, 1054;m/z (ESI) 306.7 (M+).
2.3.2.2. 4-((2-Aminophenylimino)(phenyl)methyl)-3-methyl-1-
phenyl-1H-pyrazol-5-ol 5b. Recrystallized from ethanol (yield
83%), obtained as orange crystals. mp 223–225 C. Anal.
Calcd for C23H20N4O (368.43): C, 74.98; H, 5.47; N, 15.21.
Found: C, 75.12; H, 5.50; N, 15.25; 1H NMR (DMSO-d6) d;
1.44 (s, 3H, CH3), 5.43 (s, 2H, NH2), 6.27–8.05 (m, 14H, Ar-
H), 12.13 (s, 1H, OH); 13C NMR (DMSO-d6) d; 16.0,
100.97, 115.89, 116.18, 118.54, 122.53, 124.33, 128.28, 128.48,
128.66, 128.70, 128.88, 129.23, 130.61, 131.91, 139.58, 144.80,
147.90, 165.95; IR mmax cm
1(KBr): 3407, 3333, 1630, 1396,
1054. m/z (ESI) 368.6 (M+).
2.3.2.3. 4-((3-Amino-2-methylphenylimino)(phenyl)methyl)-3-
methyl-1-phenyl-1H-pyrazol-5-ol 5c. Recrystallized from etha-
nol (yield 73%), obtained as yellow crystals. mp above
250 C. Anal. Calcd for C24H22N4O (382.45): C, 75.37; H,
5.80; N, 14.65. Found: C, 75.17; H, 5.83; N, 14.59; 1H NMR
(CDCl3) d; 1.60 (s, 3H, CH3), 2.28 (s, 3H, CH3), 4.95 (s, 2H,
NH2), 6.27–8.04 (m, 13H, Ar-H), 12.81 (s, 1H, OH);
13C
NMR (CDCl3) d; 12.31, 16.06, 101.13, 119.38, 124.47,
126.29, 126.35, 128.35, 128.46, 128.66, 128.78, 128.83, 130.24,
131.45, 136.79, 138.98, 142.84, 148.05, 163.91, 166.03; IR mmax
Table 1 Physicochemical properties of new synthesized Schiff bases 5h–i.
Entry Compd. R X Yield (%) Time (h)
1 5a CH3 –C6H4(ortho)– 60 2.5
2 5b Ph –C6H4(ortho)– 83 2.5
3 5c Ph, –(2-Me)C6H3(meta)– 73 3.0
4 5d Ph –C6H4(para)– 65 3.0
5 5e C3H7 –C6H4(ortho)– 83 2.5
6 5f C3H7 –(2-Me)C6H3(meta)– 68 2.0
7 5g C3H7 –C6H4(para)– 75 2.5
8 5h Ph –C6H4(meta)– 78 3.0
9 5i C3H7 –C6H4(meta)– 70 3.5
38 N. Parmar et al.cm1 (KBr): 3472, 3386, 1620, 1387, 1052; m/z (ESI) 382.9
(M+).
2.3.2.4. 4-((4-Aminophenylimino)(phenyl)methyl)-3-methyl-1-
phenyl-1H-pyrazol-5-ol 5d. Recrystallized from ethanol (yield
65%), obtained as yellow crystals. mp 172–174 C.Anal. Calcd
for C23H20N4O (368.43): C, 74.98; H, 5.47; N, 15.21. Found: C,
75.17; H, 5.52; N, 15.34; 1HNMR (CDCl3) d; 1.60 (s, 3H, CH3),
3.52 (s, 2H, NH2), 6.63–8.02 (m, 14H, Ar-H), 12.89 (1H, s, OH);
13C NMR (CDCl3) d; 15.91, 100.00, 117.53, 119.42, 121.97,
124.55, 125.14, 125.84, 127.43, 128.87, 131.51, 132.57, 138.92,
144.8, 147.90, 162.30, 165.67; IR mmax cm
1 (KBr): 3409, 3332,
1631, 1388, 1053. m/z (ESI) 369.0 (M+).
2.3.2.5. 4-(1-(2-Aminophenylimino)butyl)-3-methyl-1-phenyl-
1H-pyrazol-5-ol 5e. Recrystallized from ethanol (yield 83%),
obtained as yellow crystals. mp 183–185 C. Anal. Calcd for
C20H22N4O (334.41): C, 71.83; H, 6.63; N, 16.75. Found: C,
72.03; H, 6.66; N, 16.78; 1H NMR (CDCl3) d; 0.90 (t, 3H, J
7.2 Hz, CH3), 1.58 (m, 2H, CH2), 2.44 (s, 3H, CH3), 2.57 (t,
2H, J 8.0 Hz, CH2), 3.87 (s, 2H, NH2), 6.79–8.02 (m, 9H,
Ar-H), 12.58 (s, 1H, OH); 13C NMR (CDCl3) d; 14.24,
16.83, 22.69, 31,22, 99.76, 116.52, 118.84, 119.43, 122.33,
124.52, 128.03, 128.78, 129.45, 138.92, 142.26, 146.91, 166.23,
170.37; IR mmax cm
1 (KBr): 3420, 3342, 1628, 1395, 1054;
m/z (ESI) 334.7 (M+).
2.3.2.6. 4-(1-(3-Amino-2-methylphenylimino)butyl)-3-methyl-
1-phenyl-1H-pyrazol-5-ol 5f. Recrystallized from ethanol (yield
68%), obtained as white crystals. mp 182–183 C. Anal. Calcd
for C21H24N4O (348.44): C, 72.39; H, 6.94; N, 16.08. Found:
C, 72.58; H, 6.95; N, 16.12; 1H NMR (DMSO-d6) d; 0.81 (t,
3H, J 7.4 Hz, CH3), 1.46 (m, 2H, CH2), 1.96 (s, 3H, CH3),
2.37 (s, 3H, CH3), 2.56 (t, 2H, J 8.4 Hz, CH2), 5.20 (s, 2H,
NH2), 6.51–8.01 (m, 8H, Ar-H), 12.75 (s, 1H, OH);
13C
NMR (DMSO-d6) d; 12.25, 14.37, 16.93, 22.33, 30.78, 99.48,
114.38, 114.78, 117.42, 118.60, 124.32, 127.02, 129.16, 135.75,
139.51, 147.23, 148.55, 166.24, 169.62; IR mmax cm
1 (KBr):
3446, 3358, 1624, 1383, 1051. m/z (ESI) 348.5 (M+).
2.3.2.7. 4-(1-(4-Aminophenylimino)butyl)-3-methyl-1-phenyl-
1H-pyrazol-5-ol 5g. Recrystallized from ethanol (yield 75%),
obtained as yellow crystals. mp 181–183 C. Anal. Calcd for
C20H22N4O (334.41): C, 71.83; H, 6.63; N, 16.75. Found: C,
71.67; H, 6.68; N, 16.71; 1H NMR (CDCl3) d; 0.95 (t, 3H, J
7.2 Hz, CH3), 1.59 (m, 2H, CH2), 2.44 (s, 3H, CH3), 2.63 (t,
2H, J 8.6 Hz, CH2), 4.73 (s, 2H, NH2), 6.81–8.01 (m, 9H,Ar-H), 12.85 (s, 1H, OH); 13C NMR (CDCl3) d; 14.17,
16.88, 22.92, 30.78, 99.05, 116.68, 116.74,119.41, 124.41,
126.49, 127.28, 128.51, 128.74, 139.04, 142.26, 146.80, 166.04,
168.67; IR mmax cm
1 (KBr): 3372, 3338, 1612, 1390, 1054.
m/z (ESI) 337.0 (M+).
2.3.2.8. N,N0-bis-[1-(5-Hydroxy-3-methyl-1-phenyl-1H-pyra-
zol-4-yle)-phenyl-methylene]-benzene-1,3-diamine 5h. Recrys-
tallized from ethanol (yield 78%), obtained as yellow
crystals. mp 229–230 C. Anal. Calcd for C40H32N6O2
(628.72): C, 76.41; H, 5.13; N, 13.37. Found: C, 76.58; H,
5.10; N, 13.28; 1H NMR (CDCl3) d; 1.59 (s, 6H, CH3), 6.37–
8.02 (m, 24H, Ar-H), 12.79 (s, 2H, OH); 13C NMR (CDCl3)
d; 15.95, 101.79, 119.32, 119.60, 121.68, 124.70, 128.46,
128.82, 128.98, 129.41, 130.80, 131.00, 138.29, 138.69, 148.07,
161.93 165.57; IR mmax cm
1 (KBr): 3424, 1374, 1051; m/z
(ESI) 629.2 (M+).
2.3.2.9. N,N’-bis[1-(5-Hydroxy-3-methyl-1-phenyl-1H-pyrazol-
4-yle)-butylidene]-benzene-1,3-diamine 5i. Recrystallized from
ethanol (yield 70%), obtained as white crystals. mp 180–
182 C. Anal. Calcd for C34H36N6O2 (560.69): C, 72.83; H,
6.47; N, 14.99. Found: C, 72.90; H, 6.43; N, 15.11; 1H NMR
(CDCl3) d; 0.97 (t, 6H, J 7.6 Hz, CH3), 1.62 (m, 4H, CH2),
2.48 (s, 6H, CH3), 2.74 (t, 4H, J 8.4 Hz, CH2), 7.17–8.01 (m,
14H, Ar-H), 13.22 (s, 2H, OH); 13C NMR (CDCl3) d; 14.11,
16.91, 22.90, 30.75, 100.16, 119.43, 123.75, 124.73, 125.31,
128.79, 130.82, 138.43, 138.66, 146.83, 165.95, 167.55; IR mmax
cm1(KBr): 3424, 1374, 1054; m/z (ESI) 560.8 (M+).
2.4. Biological evaluation of the synthesized compounds 5a–i
2.4.1. Antimicrobial activity
Biological assays were carried out by the agar cup diffusion
method (Venkatraman et al., 1999; Cruickshank et al., 1975).
A nutrient agar cup was prepared by dissolving a weighed
ingredient in water at 7–6 pH. An aliquot (25 mL) was then
dispensed in different test tubes followed by plugging them
with sterilized cotton wool. By a gentle shaking, poured a well
mixed incubated 0.5–0.6 mL 24 h old culture into a sterilized
petri dish (25 mL each) and was allowed to set for 1.5 h. Cups
were made by punching agar surface with a sterile cork bore
and punched part of the agar media was removed by scooping.
Each cup was added a sample solution (400 lg/mL DMF).
Plates were then incubated at 35 C for 24–48 h to observe
growth. Inhibition zones were measured in millimetres. Strep-
tomycin and griseofulvin were used as standard antibacterial
Synthesis, antimicrobial and antioxidant activities of some 5-pyrazolone based Schiff bases 39and antifungal drugs respectively. Solvent was screened for its
activity. The corrections in biological activity of the com-
pound, due to solvent dimethylformamide (DMF) were also
applied in the calculation. DMF gave zero inhibition against
Bacillus subtilis as well as Escherichia coli, but showed
3.0 mm against Phytophthora infestanse and Aspergillus niger.
2.4.2. Antioxidant activity
Ferric reducing antioxidant power (FRAP) was measured by a
modiﬁed method of Benzie and Strain (Benziea and Strainb,
1996). The antioxidant potentials of the compounds were esti-
mated as their power to reduce the TPTZ–Fe(III) complex to
TPTZ–Fe(II) complex (FRAP assay), which is simple, fast,
and reproducible. FRAP working solution was prepared by
mixing a 25.0 mL, 10 mM TPTZ solution in 40 mM HCl,
20 mM FeCl3Æ6H2O and 25 mL, 0.3 M acetate buffer at pH
3.6. A mixture of 40.0 lL, 0.5 mM sample solution and
1.2 mL FRAP reagent was incubated at 37 C for 15 min.
Absorbance of intensive blue colour [Fe(II)–TPTZ] complex
was measured at 593 nm. The ascorbic acid was used as a stan-
dard antioxidant compound. The results are expressed as
ascorbic equivalent (mmol/100 g of dried compound).
3. Results and discussion
3.1. Chemistry
4-Acetyl/benzoyl-5-pyrazolones 3a–b were obtained by a meth-
od reported elsewhere (Jenson, 1956) (Scheme 1). Similarly, 4-
butyryl-5-pyrazolone 3c was obtained from butyrylchloride 2c
but at modiﬁed room temperature method (Okafor et al.,
1993). Yields were 75% (3a), 72% (3b) and 67% (3c). Equimo-
lar 3a–c with diamines 4a–d in the presence of a few drops of
acetic acid under reﬂuxing ethanol gave Schiff bases 5a–g
(Table 1, entries 1–7; Scheme 1, Path a). Schiff bases 5a–g that
formed from o- or p-phenylenediamines were monoketiminic
and bisketiminic 5h–i from m-phenylenediamine (Table 1,
entries 8–9; Scheme 1, Path b). IR, 1H NMR and 13C NMR
spectroscopic data are in good agreement with their proposed
structure. A displacement of a mOH band from region 3650–Table 2 Antimicrobial and antioxidant activities of compounds 5a–
i.e. antimicrobial, antifungal or antioxident, among the compounds.
Compound Antibacterial activity
B. subtilis Gram +ve E. coli Gram ve
5a 0.0 3.0
5b 2.0 5.0
5c 4.0 3.0
5d 0.0 3.0
5e 0.0 3.0
5f 4.0 4.0
5g 4.0 3.0
5h 5.0 2.5
5i 0.0 2.5
DMF 0.0 0.0
Streptomycinb 10.0 10.0
Griseofulvinb NT NT
a 400 lg/mL in DMF, Inhibition zone measured in mm.
b 100 lg/mL in DMF, Inhibition zone measured in mm.
c NT =Not tested.3500 cm1 to 3350–2800 cm1 may be due to an internal
hydrogen bridge OH  N‚C (Ueno and Martell, 1956;
Faniram et al., 1974). The band sometimes remained
undetected if a strong hydrogen bond exists. So, Schiff bases
are relatively planar with an adequate intramolecular distance
favouring hydrogen bond formation (Freedman, 1961). Elec-
tronegative group attached to nitrogen favours the intra/inter-
molecular hydrogen bonding (Freedman, 1961). The
compounds exist in enolic form (Scheme 1). Greater the elec-
tron density on C‚N, weaker this bond becomes and its
stretching frequency appears at a lower wave number. IR spec-
tra of compounds 5a–g show a doublet in the 3500–3000 cm1
range due to NH2 which is absent in 5h–i. All the compounds
5a–i show bands in the 3500–3000 cm1 range, and 1055 cm1
attributed to phenolic OH and C‚N groups respectively. The
bands at 1595 and 1320 cm1 are attributable to cyclic
mC‚N and a mC–O respectively.
1H NMR spectra of 5e show three peaks; a triplet at d 0.90, a
multiplet at 1.58, and a triplet at 2.57 ppm which are attributed
to n-propyl hydrogens. A singlet peak appearing around d
2.44 ppm is due to methyl protons attached to pyrazolone unit.
The NH2 protons resonate as a broad singlet at d 3.8 ppm,
whereas signal due to phenolic proton was observed around d
12 ppm. Aromatic protons appeared as multiplet in the d 6.79–
8.04 ppm range. Absence of a broad singletd 3–4 ppm in com-
pounds 5h–i is due to bisketimino of Schiff base.13CNMR spec-
tra of 5h–i are in good agreement with their proposed structure.
It showed that a peak in the d 12–17 ppmrange is due toCH3 car-
bon. The compound CH2 gives two negative signals; one at d 22
and second at 30 ppm inDEPT-135. A distinctive peak in d 166–
170 ppm range is assigned to carbon attached to the oxygen
atom. A signal at d100 ppm indicates the carbon at position-
4 of the pyrazole ring. All the aromatic carbon signals appeared
in d 110.08–160.74 ppm range conﬁrming the proposed struc-
ture of 5a–i. Themass spectra agreed with the molecular ion sig-
nals corresponding to the respective molecular formula of the
synthesized compounds. For example, mass spectra of com-
pound 5a gave molecular ion peak at 306.7 (M+) corresponding
to the molecular formula C18H18N4O. The observed values of C
H N elemental analysis are in good agreements with the calcu-
lated data.ia. The bold values indicate highest values of respective properties
Antifungal activity Antioxidant activity
P. infestanse A. niger FRAP value (mmol/100 g)
5.0 6.0 13.2
9.0 6.0 30.6
6.0 2.0 17.9
7.0 5.0 95.0
9.0 5.0 20.5
6.0 5.0 25.6
7.0 5.0 37.0
8.0 2.0 31.8
7.0 5.0 75.4
3.0 3.0 NT
NTc NT NT
9.0 9.0 NT
40 N. Parmar et al.3.2. Biological evaluation
3.2.1. Antimicrobial activity
The antimicrobial screening test results exhibited a poor activ-
ity compared to other standard drugs. From activity data
(Table 2), it shows that compounds 5b and 5h exhibited mod-
erate activity against E. coli and B. subtilis respectively in com-
parison to standard antibiotic streptomycin. On the other
hand antifungal study shows excellent activity against P. infe-
stanse and Aspergillus fumigates. Compared to a standard gris-
eofulvin, compounds 5b, 5e and 5h exhibited excellent activity
against P. infestanse. Thus, from the structural examination, it
concludes that Schiff bases, particularly, from 4-butyryl-5-pyr-
azolone possess good antibacterial and antifungal activities
which may be due to electronegative alkyl group (Waksman,
1947).
3.2.2. Antioxidant activity
A capacity to transfer a single electron i.e. the antioxidant
power of all compounds was determined by a FRAP assay.
The FRAP value was expressed as an equivalent of standard
antioxidant ascorbic acid (mmol/100 g of dried compound).
FRAP values indicate that all the compounds have a ferric-
reducing antioxidant power. The compounds 5d and 5i showed
relatively high antioxidant activity while compound 5a shows
poor antioxidant power (Table 2).
4. Conclusion
In summary, we afforded two types of Schiff base compounds;
a bisketimine and monoketimine depending upon the nature of
aromatic diamines. m-phenylenediamine gave bisketiminic
Schiff bases, while o- or p-, and 2-methyl-m-phenylenediamine
afforded a monoketiminic one. All synthesized compounds are
active against gram positive bacteria – B. subtilis and
P. infestanse. Schiff bases derived from butyrylpyrazolone
showed good antibacterial and antifungal activities. While
those from acetylpyrazolones showed substantially a low anti-
oxidant activity, very high antioxidant power was shown by
the Schiff bases from 4-butyryl-5-pyrazolones.Acknowledgements
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